GSDMB and Crohn disease: GSDMB showed predominantly protective effects: increased expression in multiple T‐cell subsets associated with lower risk of UC, Crohn disease, rheumatoid arthritis, and ankylosing spondylitis, but showed an opposite liability in primary sclerosing cholangitis.